Severin Investments, LLC Astrazeneca PLC Transaction History

Severin Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Dec 03, 2025	SELL	$68.72 - $82.11 $520,416 - $621,819	-7,573 Closed	0 $0
Q2 2025 Dec 03, 2025	SELL	$64.87 - $75.0 $10,054 - $11,625	-155 Reduced 2.01%	7,573 $529 Million
Q1 2025 Dec 03, 2025	BUY	$65.37 - $77.96 $18,499 - $22,062	283 Added 3.8%	7,728 $568 Million
Q4 2024 Dec 03, 2025	BUY	$63.2 - $79.58 $470,524 - $592,473	7,445 New	7,445 $488 Million

1,502

500M

5.64M

3.2M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Severin Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Severin Investments, LLC with notifications on news.